AU2022267110A1 - Composition for ameliorating or suppressing decline of kidney functions - Google Patents

Composition for ameliorating or suppressing decline of kidney functions Download PDF

Info

Publication number
AU2022267110A1
AU2022267110A1 AU2022267110A AU2022267110A AU2022267110A1 AU 2022267110 A1 AU2022267110 A1 AU 2022267110A1 AU 2022267110 A AU2022267110 A AU 2022267110A AU 2022267110 A AU2022267110 A AU 2022267110A AU 2022267110 A1 AU2022267110 A1 AU 2022267110A1
Authority
AU
Australia
Prior art keywords
composition
renal function
ergothioneine
salt
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022267110A
Other languages
English (en)
Inventor
Makoto Katsube
Norihito Murayama
Hiroshi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of AU2022267110A1 publication Critical patent/AU2022267110A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2022267110A 2021-04-26 2022-03-25 Composition for ameliorating or suppressing decline of kidney functions Pending AU2022267110A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021074321 2021-04-26
JP2021-074321 2021-04-26
PCT/JP2022/014246 WO2022230491A1 (ja) 2021-04-26 2022-03-25 腎機能の低下抑制又は改善用組成物

Publications (1)

Publication Number Publication Date
AU2022267110A1 true AU2022267110A1 (en) 2023-10-05

Family

ID=83847930

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022267110A Pending AU2022267110A1 (en) 2021-04-26 2022-03-25 Composition for ameliorating or suppressing decline of kidney functions

Country Status (7)

Country Link
US (1) US20240173298A1 (https=)
EP (1) EP4331581A4 (https=)
JP (1) JP7764471B2 (https=)
CN (1) CN117241796A (https=)
AU (1) AU2022267110A1 (https=)
TW (1) TW202308613A (https=)
WO (1) WO2022230491A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230000829A1 (en) * 2019-10-28 2023-01-05 Suntory Holdings Limited Composition for sleep improvement comprising ergothioneine or salt thereof
CN121001582A (zh) * 2023-03-28 2025-11-21 三得利控股株式会社 含有麦角硫因或其盐的用于预防、减轻或改善中暑或脱水症的组合物及用于调节细胞内外水分的组合物
CN120241721A (zh) * 2025-04-25 2025-07-04 武汉大学中南医院 麦角硫因在制备肾损伤保护药物的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110604A1 (en) * 2000-08-11 2002-08-15 Ashni Naturaceuticals, Inc. Composition exhibiting synergistic antioxidant activity
JP5658479B2 (ja) 2009-04-27 2015-01-28 株式会社岩出菌学研究所 脂肪減少等の活性を示す組成物
US20120141611A1 (en) * 2010-12-05 2012-06-07 Oxis International Inc. Methods and compositions using ergothioneine to treat a variety of health related factors
US20140121156A1 (en) * 2011-06-13 2014-05-01 Entia Biosciences, Inc. Nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine
CA3122246C (en) * 2018-12-05 2025-06-10 Celagenex Research (India) Pvt. Ltd. Synergistic compositions of bioactive agents to optimize cell health
JP7424593B2 (ja) * 2019-07-26 2024-01-30 フンダシオ・インスティトゥート・ディンヴェスティガシオ・ビオメディカ・デ・ベルヴィッチ（イディベル） エルゴチオネイン、ｓ－メチル－エルゴチオネイン、及びそれらの使用
CN113308378B (zh) * 2020-02-26 2022-11-29 华南农业大学 高产麦角硫因的灵芝菌株及其应用

Also Published As

Publication number Publication date
TW202308613A (zh) 2023-03-01
JP7764471B2 (ja) 2025-11-05
WO2022230491A1 (ja) 2022-11-03
EP4331581A4 (en) 2025-04-09
JPWO2022230491A1 (https=) 2022-11-03
US20240173298A1 (en) 2024-05-30
EP4331581A1 (en) 2024-03-06
CN117241796A (zh) 2023-12-15

Similar Documents

Publication Publication Date Title
US20240173298A1 (en) Composition for ameliorating or suppressing decline of kidney functions
EP4331580A1 (en) Composition for increasing red blood cells and/or hemoglobin
JP7757450B2 (ja) エルゴチオネイン又はその塩を含有する睡眠改善用組成物
US20240180877A1 (en) Anti-anxiety composition
EP4331680A1 (en) Composition for increasing leukocytes and/or basophils
US20240189284A1 (en) Composition for promoting lipolysis
US20240156785A1 (en) Composition for improving blood cholesterol level
US20250017905A1 (en) Composition for inhibiting histamine-n-methyltransferase
HK40103317A (zh) 肾功能的降低抑制或改善用组合物
WO2024203675A1 (ja) エルゴチオネイン又はその塩を含有する熱中症又は脱水症を予防、軽減又は改善するための組成物及び細胞内外水分を調節するための組成物
HK40113453A (zh) 口服组合物以及抑制来自麦角硫因的苦味的方法
WO2024172002A1 (ja) エルゴチオネインを含有する血管拡張用組成物
AU2022417968A1 (en) Oral composition and method for suppressing bitterness derived from ergothioneine
WO2024172003A1 (ja) エルゴチオネインを含有する筋萎縮抑制用組成物及びＳｒｃチロシンキナーゼ阻害用組成物
AU2023318410A1 (en) Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof and odor derived from milk-derived ceramide-containing material
HK40103316A (zh) 红血球及/或血红蛋白增加用组合物
HK40075030A (en) Composition for sleep improvement comprising ergothioneine or salt thereof
HK40104490A (zh) 脂肪分解促进用组合物